GIMS CMI the 1st Government Hospital–Based Incubator in Uttar Pradesh Nurtures Startup Raising USD 2 Million (₹16.6 Crore) Seed Funding
A breakthrough moment for India’s public hospital innovation ecosystem
Greater Noida, Uttar Pradesh —
The Centre for Medical Innovation (CMI) at the Government Institute of Medical Sciences (GIMS), Greater Noida has created national history. A startup nurtured inside this government hospital–based incubator has successfully raised USD 2 million (approximately ₹16.6 crore) in seed funding led by Bluehill.VC, along with a prestigious Design-Linked Incentive (DLI) Grant from the Government of India.
CMI operates at GIMS and is a State Government Section 8 company established to run the medical incubator at GIMS under the Department of Medical Education, Government of Uttar Pradesh.
This achievement firmly positions Uttar Pradesh as a rising leader in India’s MedTech innovation landscape.
From “Impossible” to “National Model”
Building a medical incubator inside a government hospital was once seen as nearly impossible. Standard incubation frameworks designed for engineering or technology institutes do not work within a hospital ecosystem.
Despite the odds, CMI–GIMS built a completely new model — from scratch:
• Clinical Startup OPD clinics
• Real-world clinical immersion
• A structured clinical mentorship framework
• Validation pathways for medical devices and med-AI
• India’s first government hospital–driven innovation culture
Backed by the vision and support of the Government of Uttar Pradesh, this once-unthinkable initiative has become a nationally replicable model.
About the Startup: Sophrosyne Technologies
Sophrosyne Technologies is a pioneering health-tech startup developing India’s own medical-grade chipsets for next-generation wearables and medical devices — a domain currently dominated by imports.
The company is founded by:
• Manish Srivastava, PhD (Biosensors), University College Cork, Ireland — researcher with several granted patents
• Jatin Gupta — 15+ years of global experience in business strategy & operations
What Sophrosyne is Building
India depends heavily on imported chipsets for medical and health devices. Sophrosyne is changing this by creating indigenous, ultra-low-power, clinically accurate health chipsets that integrate:
• Multi-vital biosensing
• Smart power management
• Proprietary AI for real-time health-risk prediction and prevention
Alongside these chipsets, the company is developing energy-harvesting technologies to power future invasive and non-invasive medical devices.
Impact & Industry Recognition
Sophrosyne has already attracted interest from leading medical and consumer device manufacturers in India and the UK.
It is also a select recipient of DLI grants, highlighting strong government confidence in its mission and strategic importance.
CMI–GIMS’ Impact on Their Journey
The founders shared:
“The tremendous support from GIMS Noida has significantly accelerated our journey. Their insights into real-world healthcare delivery challenges have been invaluable. The world-class ecosystem GIMS is cultivating to nurture HealthTech startups like ours is directly fueling the ‘Make in India’ mission.”
They also expressed sincere gratitude:
“We extend our heartfelt thanks to Dr. Rakesh Gupta, Director, GIMS, and Dr Rahul Singh CEO of GIMS Incubation Centre for his guidance and support throughout our journey.”
With strong ecosystem backing, Sophrosyne aims to build a world-class Indian technology company leveraging advanced system-on-chip design and AI to solve critical healthcare challenges.
A Growing National Platform
CMI–GIMS today supports:
• 40+ active startups
• Stanford BIODESIGN centre, Problem Bank, Idea Bank, regulatory clinic, Startup clinic
• India’s first OPD-based Startup Clinics
• Collaborations with IIT Kanpur, IIT Mandi, IIITs, and leading national incubators
This model is rapidly transforming India’s approach to clinical validation, medical device development, MedTech entrepreneurship, and healthcare innovation.
Leadership Statement
“This milestone is more than a funding event — it is proof that India’s public hospitals can become powerful engines of MedTech innovation. What began as an ‘impossible’ idea inside a government hospital has now become a model for the nation.”
— Dr Rahul Singh
CEO – Centre for Medical Innovation (CMI), GIMS (Government Institute of Medical Sciences, Greater Noida)
About CMI–GIMS
The Centre for Medical Innovation (CMI) is the official innovation and startup incubation arm of the Government Institute of Medical Sciences (GIMS), Greater Noida.
It is registered as a State Government Section 8 company under the Department of Medical Education, Government of Uttar Pradesh, with a mandate to:
• run the medical incubator at GIMS,
• provide clinical mentoring,
• conduct device validation & trials,
• support regulatory readiness,
• operate Startup OPD clinics, and
• build innovation capacity inside public hospitals.
CMI–GIMS is Uttar Pradesh’s first public hospital–based medical incubator and a rising national model.
Explore more
🎤 Career – Real career stories and job profiles of life science professionals. Discover current opportunities for students and researchers.
💼 Jobs – The latest job openings and internship alerts across academia and industry.
🛠️ Services – Regulatory support, patent filing assistance, and career consulting services.
